About Johns Hopkins
spacer for safari
From the home page

Taking the sting out of malaria

Malaria Research
Nirbhay Kumar uses bacteria from the mosquito's
gut to create a potential vaccine for humans. (Photo: Mark Lee)

An itchy annoyance to most of us, a mosquito bite is more alarming - and potentially deadly - to millions across the world. About half a billion people are infected with malaria each year through the bite of a mosquito. More than one million die from the disease annually.

For nearly a decade the Johns Hopkins Malaria Research Institute - housed within the Bloomberg School of Public Health - has been dedicated to treating and preventing the disease. The team committed to the eradication of this worldwide health scourge is based in Baltimore, conducting breakthrough research and providing classroom instruction to Johns Hopkins University students.

In July, the institute published a study that it had produced a malarial protein with the potential to create a transmission-blocking vaccine.

"This is an exciting beginning to what might become an important tool in the arsenal for malaria control and progressive elimination of malaria transmission," said Nirbhay Kumar, PhD, senior author of the study and professor in Johns Hopkins Bloomberg School of Public Health's W. Harry Feinstone Department of Molecular Microbiology and Immunology.

The Malaria Research Institute is just one of more than 50 research centers housed at the Johns Hopkins Bloomberg School of Public Health.

Founded in 1916, the Johns Hopkins Bloomberg School of Public Health was the first of its kind and remains the largest in the world. It draws the most highly qualified candidates internationally with 2,000 students enrolled from 84 nations.

Explore Further: